The 3D Genome: EZH2 Comes into the Fold.
Trends Mol Med
; 25(5): 362-365, 2019 05.
Article
in En
| MEDLINE
| ID: mdl-30885427
EZH2 is an oncogene in non-Hodgkin lymphoma. Understanding the underlying pathogenic mechanisms will be essential to improve treatments for patients with EZH2 mutant lymphomas. Recently Donaldson-Collier and colleagues (Nat. Genet. 2019; published online January 28, https://doi.org/10.1038/s41588-018-0338-y) examined the effects of mutant EZH2 on the 3D architecture of the lymphoma genome, highlighting the potential relevance of chromatin folding dynamics.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
Genetic Predisposition to Disease
/
Genomics
/
Genome-Wide Association Study
/
Enhancer of Zeste Homolog 2 Protein
/
Mutation
Limits:
Humans
Language:
En
Journal:
Trends Mol Med
Journal subject:
BIOLOGIA MOLECULAR
Year:
2019
Document type:
Article
Affiliation country:
Ireland
Country of publication:
United kingdom